Media:
media@abogenbio.com
media@abogenbio.com
-
2022-09-30Abogen’s COVID-19 mRNA Vaccine granted Emergency Use Authorization (EUA) in Indonesia -
2021-11-29Abogen Biosciences Closes $300 Million Series C+ Financing
-
2021-08-19Abogen Biosciences Secures Over $700 Million in Series C Financing to Accelerate its mRNA Platform Across Multiple Vaccines and Diverse Therapeutic Fields
-
2021-04-07Abogen Biosciences Closes ¥600 Million Series B Financing
-
2020-10-27Abogen Biosciences Closes ¥150 Million Series A Financing
-
2020-06-19Abogen Biosciences' First mRNA Vaccine Got Approval for Clinical Trials